Taille et prévisions du marché des médicaments pour le système endocrinien (2021-2031), part mondiale et régionale, tendances et analyse des opportunités de croissance

  • Report Code : TIPRE00027654
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

APERÇU DU MARCHÉ Le système endocrinien est un système messager qui régule des organes cibles distants via des boucles de rétroaction d'hormones sécrétées par les glandes internes d'un organisme directement dans le système circulatoire. L'hypothalamus est le centre de contrôle neurologique de tous les systèmes endocriniens chez les animaux. Les glandes thyroïde et les glandes surrénales sont les deux principales glandes endocrines chez l'homme. Les hormones sont classées pharmacologiquement comme des médicaments et peuvent être des produits chimiques naturels, semi-synthétiques ou synthétiques. Les médicaments endocriniens sont des médicaments qui ciblent un système endocrinien défectueux. ÉTENDUE DU MARCHÉ L'analyse du marché des médicaments pour le système endocrinien" est une étude spécialisée et approfondie du secteur de la santé avec un accent particulier sur l'analyse des tendances du marché mondial. Le rapport vise à fournir un aperçu du système endocrinien. Marché des médicaments avec une segmentation détaillée du marché par type, application et géographie. Le rapport fournit des statistiques clés sur l’état du marché des acteurs et présente les principales tendances et opportunités du marché des médicaments pour le système endocrinien. SEGMENTATION DU MARCHÉ < ul> • Sur la base du type, le marché des médicaments du système endocrinien est segmenté en médicaments contre le diabète, hormones de croissance humaine, médicaments contre les troubles des hormones thyroïdiennes et autres. • En fonction de l'application, le marché est segmenté en hôpitaux, cliniques, centres médicaux. DYNAMIQUE DU MARCHÉ Moteurs :
    • Les problèmes liés au système endocrinien sont de plus en plus courants. • Nouveaux médicaments et combinaisons pharmaceutiques pour le traitement des troubles endocriniens. problèmes. • L'adoption rapide de nouvelles formes posologiques et formulations de médicaments existants.
Contraintes :
    • Manque de médicaments prospectifs et efficaces contre le diabète. • Le coût élevé des tests endocriniens modernes
Le rapport fournit un aperçu détaillé de l'industrie, y compris des informations qualitatives et quantitatives. Il fournit un aperçu et des prévisions du marché mondial en fonction de divers segments. Il fournit également la taille du marché et des estimations prévisionnelles pour la période 2021 à 2031 pour cinq grandes régions, à savoir : Amérique du Nord, Europe, Asie-Pacifique (APAC), Moyen-Orient et Afrique (MEA) et Amérique du Sud. Le marché des médicaments pour le système endocrinien de chaque région est ensuite sous-segmenté par pays et segments respectifs. Le rapport couvre l'analyse et les prévisions de 18 pays dans le monde ainsi que la tendance actuelle et les opportunités qui prévalent dans la région. Le rapport analyse les facteurs affectant le marché du côté de la demande et de l’offre et évalue plus en détail la dynamique du marché affectant le marché au cours de la période de prévision, c’est-à-dire les moteurs, les contraintes, les opportunités et les tendances futures. Le rapport fournit également une analyse PEST exhaustive pour les cinq régions, à savoir : Amérique du Nord, Europe, APAC, MEA et Amérique du Sud après avoir évalué les facteurs politiques, économiques, sociaux et technologiques affectant le marché des médicaments pour le système endocrinien dans ces régions. IMPACT DU COVID-19 SUR LE MARCHÉ DES MÉDICAMENTS DU SYSTÈME ENDOCRINIEN Le COVID-19 est apparu pour la première fois à Wuhan (Chine) en décembre 2021, et depuis lors, il s'est propagé à un rythme rapide à travers le monde. Les États-Unis, l’Inde, le Brésil, la Russie, la France, le Royaume-Uni, la Turquie, l’Italie et l’Espagne comptent parmi les pays les plus touchés en termes de cas confirmés et de décès signalés. La pandémie a affecté la croissance de ce marché à l’échelle mondiale en raison de la fermeture des activités, du confinement mondial et des perturbations de l’approvisionnement et du commerce. ACTEURS DU MARCHÉ Le rapport couvre les développements clés du marché des médicaments pour le système endocrinien en tant que stratégies de croissance organique et inorganique. Diverses entreprises se concentrent sur des stratégies de croissance organique telles que les lancements de produits, les approbations de produits et d'autres telles que les brevets et les événements. Les activités de stratégies de croissance inorganiques observées sur le marché étaient des acquisitions et des partenariats partiels. Ces activités ont ouvert la voie à l’expansion de l’activité et de la clientèle des acteurs du marché. Les acteurs du marché des médicaments pour le système endocrinien devraient avoir des opportunités de croissance lucratives à l’avenir avec la demande croissante de médicaments pour le système endocrinien sur le marché mondial. Le rapport comprend également les profils d’entreprises clés ainsi que leur analyse SWOT et leurs stratégies de marché sur le marché des médicaments pour le système endocrinien. En outre, le rapport se concentre sur les principaux acteurs de l'industrie avec des informations telles que les profils d'entreprise, les composants et les services proposés, les informations financières des 3 dernières années, l'évolution clé des cinq dernières années.
    • Laboratoires Abbott • F.Hoffmann LaRoche Ltd. • Eli Lilly & Company • Novartis International AG • Alacer corporation • Pfizer Inc. • Facet Biotec Corporation •  Novo Nordisk • Sanofi • Merck
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are some of the major players operating in the market?

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Nevro Cor, accounting for higesh market shares and are some of the major players operating in the market

Which segment accounts for highest revenue in product type the endocrine system drugs market Market in 2023?

The Rechargeable segment accounts for highest revenue in product the endocrine system drugs market Market in 2023

Which region higesh CAGR the endocrine system drugs market Market in 2023?

Asia Pacific region dominated the endocrine system drugs market Market in 2023

Which region dominated the endocrine system drugs market Market in 2023?

North America region dominated the endocrine system drugs market Market in 2023

What is the expected CAGR of the Endocrine System Drugs Market ?

The Endocrine System Drugs Market is estimated to witness a CAGR of 8.50% from 2023 to 2031

What are the driving factors impacting the endocrine system drugs market Market?

The major factors driving the endocrine system drugs market Market are:

1.Increasing Prevalence of Chronic Pain

2. Technological Advancements

3. New Product Launches

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- Abbott Laboratories
- F.Hoffmann LaRoche Ltd.
- Eli Lilly & Company
- Novartis International AG
- Alacer corporation
- Pfizer Inc.
- Facet Biotec Corporation
- Novo Nordisk
- Sanofi
- Merck

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.